Clinical Trial

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, single arm, open label phase II clinical study evaluating the long-term efficacy and safety of SHR-1918 in homozygous familial hypercholesterolemia patients
Trial Details
NCT Number NCT07133815
Lead Sponsor Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions Homozygous Familial Hypercholesterolemia
Enrollment 55 participants
Start Date 2025-08
Primary Completion 2025-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-21